Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737 Stock Report

Market Cap: CN¥13.6b

Sunflower Pharmaceutical GroupLtd Past Earnings Performance

Past criteria checks 2/6

Sunflower Pharmaceutical GroupLtd has been growing earnings at an average annual rate of 16.7%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 7.9% per year. Sunflower Pharmaceutical GroupLtd's return on equity is 18.9%, and it has net margins of 17.8%.

Key information

16.7%

Earnings growth rate

17.3%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate7.9%
Return on equity18.9%
Net Margin17.8%
Next Earnings Update28 Aug 2024

Recent past performance updates

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Recent updates

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

Apr 16
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Mar 04
We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Revenue & Expenses Breakdown

How Sunflower Pharmaceutical GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002737 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 245,4539681,834130
31 Dec 235,7001,1191,835129
30 Sep 236,1001,2091,97595
30 Jun 235,8791,1041,94895
31 Mar 235,6621,0541,863101
01 Jan 235,0958671,75295
30 Sep 224,6758131,681132
30 Jun 224,6087991,659132
31 Mar 224,4436981,696133
01 Jan 224,4617051,670132
30 Sep 214,2716681,564142
30 Jun 213,9646551,425115
31 Mar 213,7696561,270113
31 Dec 203,4625841,185114
30 Sep 203,4275091,21292
30 Jun 203,5854971,310100
31 Mar 204,0695571,502105
31 Dec 194,3715651,659118
30 Sep 194,4885911,758124
30 Jun 194,5235861,757126
31 Mar 194,5945801,813119
31 Dec 184,4725631,803121
30 Sep 184,3695241,742127
30 Jun 184,2345151,680169
31 Mar 184,1114721,683140
31 Dec 173,8554241,608110
30 Sep 173,8554261,65574
30 Jun 173,7853281,7540
31 Mar 173,4353051,5860
31 Dec 163,3643031,5390
30 Sep 163,0452301,3780
30 Jun 163,0572911,3330
31 Mar 163,0943191,3310
31 Dec 153,0353071,2980
30 Sep 152,9813071,2830
30 Jun 152,9803191,2960
31 Mar 152,8203121,2160
31 Dec 142,7193011,2120
30 Sep 142,5672681,8560
31 Dec 132,1812631,0060

Quality Earnings: 002737 has high quality earnings.

Growing Profit Margin: 002737's current net profit margins (17.8%) are lower than last year (18.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002737's earnings have grown by 16.7% per year over the past 5 years.

Accelerating Growth: 002737's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002737 had negative earnings growth (-8.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-0.8%).


Return on Equity

High ROE: 002737's Return on Equity (18.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.